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UDC: 616-006:616-052:616.8-009.7:615-085 C ancer patients with advanced and incurable disease are as much the responsibility of oncologists as those whose disease is potentially curable. This is the message that is emanating loud and clear from The European Society of Medical Oncologists. In Europe, as in the United States, the major professional bodies have declared that oncologists must take responsibility for and be skilled in the care of their patients who cannot be cured.
Furthermore, they have asserted that this responsibility extends beyond the point when anticancer treatments may no longer be helpful.
As declared in the editorial heralding the ESMO policy statements: "the division of cancer care into an initial trial primary antitumor therapies followed by hospice or palliative care for patients who have progressive disease is anachronistic". Since the goals of medical oncology extend beyond the reduction of tumor burden and the deferral of death to incorporate a qualitative dimension, there is need for a continuum in patient care in which both primary therapies and supportive and palliative interventions are tailored to the clinical circumstances of the patient." (1) .
The care of patients with advanced and incurable cancer occupies a major part of most oncologists practice (2) . This comes as no surprise given that the cure rate for cancer remains less than 50% and that cancer continues to account for over 25% of all adult deaths (3) . ESMO recognizes that a great many patients will not be cured, and that for them the issues regarding the quality of their remaining time is critical, irrespective of the duration of survival. It has been almost five years since ESMO, at the suggestion of the then national representative from Israel (Prof Raphael Catane), established a special working group to address the relationship between medical oncology and supportive/palliative care. No one at the time would have anticipated the impact of this initiative. Since then, ESMO has clarified and ratified definitions of supportive and palliative care (Table 1) , defined the responsibilities of the oncologist in the provision of palliative and supportive care (Table 2) , outlined training requirements for oncologists in relation to these aspect of patient care (Table 3) , and established minimal standards for cancer centers (Table 4) (1).
These policies are binding upon all individual members, associated organizations and bodies, and affiliated centers. Policy statements are not enough. ESMO knew it had a problem in the actual delivery of palliative care by many oncologists, and it wanted to know exactly what and how widespread those problems were. To this end, the organization surveyed its membership to evaluate the attitudes and actual practices of ESMO affiliated oncologists. This survey (2), the most comprehensive of its kind, found that as a whole ESMO oncologists had very favorable and appropriate attitudes with regards to their responsibilities in the provision of supportive and palliative care. Overwhelmingly, they saw it as their responsibility and they expressed commitment to continuity of care and to the provision of high quality end of life care in cooperation with other health care professionals. On the downside, however, the survey found that there was a substantial gap between expressed beliefs and actual practice. For example, whereas, 88.4% of respondents agreed that medical oncologists should coordinate the care of cancer patients at all stages of disease including end of life care, in actual practice only 43% of respondents reported that they commonly coordinate the care of cancer patients at all stages of disease including end of life care, less than 50% collaborate commonly with any supportive/palliative care clinician (including social workers), only 39% commonly coordinate meetings with the family of dying patients, and only 11.8% commonly manage delirium (despite the high prevalence of this problem among patients with far advanced cancer). Interestingly, whereas 60.4% of respondents reported that they were expert in the management of the physical and psychological symptoms of advanced cancer, only 37.0% said most oncologists they knew were expert in the management of the physical and psychological symptoms of advanced cancer.
Importantly, the survey highlighted that these was a close relationship between negative attitudes toward palliative care, lack of personal care delivery, lack of consultation with palliative care colleagues from other disciplines, and "catastrophic fear" of burnout from involvement in end of life care. Those clinicians with the greatest fear did the least, had negative attitudes, and not only did they not provide care they did not refer or consult with appropriate clinicians expert in end of life care. ESMO hopes that its new education policy will better prepare oncologists for these aspects of care.
ESMO recognizes that oncologists work in a clinical context; some in private clinics, but most in hospitals and cancer centers. It is incumbent upon cancer clinics and hospitals to provide the infrastructure and supports needed to ensure adequate supportive and palliative care. All patients with advanced, potentially life threatening illness must have access to a social worker to help evaluate emotional and social coping and to assist in coordinating care. Many patients will need ambulatory or inpatient care for management of physical or psychological symptoms and, some will need access to inpatient end-of-life care. These aspects of care will need interdisciplinary cooperation, which often incorporate palliative care or hospice specialists. Not all patients needing inpatient end of life care can or will be care for in oncology departments, but it is incumbent upon the treating oncologist to ensure that this aspect of care be carries out with sensitivity and expertise. Dying patients must not be abandoned or be allowed to "fall between the cracks of the system". Consequently, the third of its policy statements descries minimal standards for supportive and palliative care to be provided by cancer centers (Table 4) . This policy applies not only to major comprehensive cancer centers, but to private clinics and hospital bases services also.
The steps taken thus far are a beginning. ESMO recognizes that it is trying to change a culture of care. Making palliative care a normative part of oncology practice, no less than the Along with the policy statements, ESMO has undertaken a series of educational and incentive programs to further promote this important endeavor. Among the most prominent of the initiatives is an incentive program to give special recognition to centers that meet an especially high standard in the integration of oncology and palliative medicine. Already more than20 centers have applied for this recognition.
This is a new direction for ESMO but it is a direction that the organization views as critical to the development of our specialty as both a humane and responsible initiative.
